Form 10QSB - Optional form for quarterly and transition reports of small business issuers:
SEC Accession No. 0001144204-05-015126
Filing Date
2005-05-13
Accepted
2005-05-13 10:32:17
Documents
5
Period of Report
2005-03-31

Document Format Files

Seq Description Document Type Size
1 v018027_10qsb.txt 10QSB 57835
2 v018027_ex31-1.txt EX-31.1 2965
3 v018027_ex31-2.txt EX-31.2 2995
4 v018027_ex32-1.txt EX-32.1 1568
5 v018027_ex32-2.txt EX-32.2 1564
  Complete submission text file 0001144204-05-015126.txt   68673
Mailing Address 712 FIFTH AVENUE 19TH FLOOR NEW YORK NY 10019
Business Address 712 FIFTH AVENUE 19TH FLOOR NEW YORK NY 10019 646 723 8944
INNOVATE ONCOLOGY, INC. (Filer) CIK: 0000894538 (see all company filings)

EIN.: 870438641 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10QSB | Act: 34 | File No.: 033-55254-28 | Film No.: 05826751
SIC: 9995 Non-Operating Establishments